Cite
HARVARD Citation
Troschke-Meurer, S. et al. (2019). Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2. Oncoimmunology. p. . [Online].